DEVAN SCOTT: Open Payments
NPI 1932812435 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,157 in 23 payments from 11 companies in 2025. Trend: 2023 $1,593 · 2024 $566 · 2025 $1,157
Food & beverage: $1,031Education: $126
| Company | Payments | Amount |
|---|---|---|
| Syndax Pharmaceuticals, Inc. | 4 | $310 |
| Astellas Pharma US Inc | 4 | $174 |
| Teleflex LLC | 1 | $154 |
| Adaptive Biotechnologies Corporation | 1 | $118 |
| SOBI, INC | 3 | $107 |
| Incyte Corporation | 3 | $87 |
| AstraZeneca Pharmaceuticals LP | 2 | $66 |
| Lilly USA, LLC | 2 | $42 |
| ABBVIE INC. | 1 | $33 |
| Merck Sharp & Dohme LLC | 1 | $33 |
Products named: ARROW, REVUFORJ, clonoSEQ, Cresemba, JAKAFI, CALQUENCE, JAYPIRCA, EPKINLY.
Industry payments across TX — which companies pay providers there.
